A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer
Denise Yardley, Howard Burris, Nancy Peacock, Eric Raefsky, Marianne Melnik, Roger Inhorn, Dianna Shipley, John HainsworthVolume:
123
Language:
english
Pages:
5
DOI:
10.1007/s10549-010-1047-0
Date:
September, 2010
File:
PDF, 171 KB
english, 2010